1) Haissaguerre M, Jais P, Shah DC, et al:Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659-666, 1998
2) Kumagai K, Nakashima H, Urata H, et al:Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. J Am Coll Cardiol 41:2197-2204, 2003
3) Kannel WB, Abbott RD, Savage DD, et al:Epidemiologic features of chronic atrial fibrillation:the Framingham Study. N Engl J Med 306:1018-1022, 1982
4) Streifler JY, Furlan AJ, Barnett HJM:Cardiogenic brain embolism;incidence, varieties, treatment. In:Stroke:pathophysiology, diagnosis, and management, 2nd ed (Barnett HJM, Stein BM, Morh JP, et al, eds), Churchill Livingstone, New York, pp967-994, 1992
5) Wolf PA, Abbott RD, Kannel WB:Atrial fibrillation as an independent risk factor for stroke:the Framingham Study. Stroke 22:983-988, 1991
6) The AFFIRM investigators:A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347:1825-1833, 2002
7) The AFFIRM investigators:Relationships between sinus rhythm, treatment, and survival in the atrial fibrillation follow-up investigation of rhythm management(AFFIRM)study. Circulation 109:1509-1513, 2004
8) Pappone C, Rosanio S, Augello G, et al:Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation, outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol 42:185-197, 2003